Seneca Investment Managers has re-invested in the Woodford Patient Capital trust through its Diversified Income and Diversified Growth funds, with the trust's current discount of 13.9% representing a "huge opportunity" for investors amid "over-emotion" about the recent underperformance of open-ended funds, according to manager Richard Parfect.
Seneca IM had originally held the now-embattled Woodford trust at IPO in 2015, before reducing its exposure in June and finally exiting entirely by the end of that year when shares were trading at around a 15% premium. Assets in underperforming 'dog' funds surge to record high as flagship Woodford fund enters list Neil Woodford's range faced 2018 performance issues within its Equity Income fund, which saw holdings, including Provident Financial and AstraZeneca, suffer extreme dips, while the Patient Capital Trust also lagged the performance of the AIC UK All Companies sector average l...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
